Related Experiment Video
Updated: Jul 6, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Wild-type p53: tumors can't stand it
1Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. michael.kastan@stjude.org
Abstract:
Most malignant tumors disrupt the p53 signaling pathway in order to grow and survive. Although many genes in addition to p53 are mutated in tumors, recent studies by Ventura et al. (2007) and Xue et al. (2007) suggest that restoring p53 function alone is sufficient to cause regression of several different tumor types in mice and thus might represent a potent therapeutic strategy to treat certain human cancers. Martins et al. (2006) also demonstrate that restoration of p53 activity results in tumor regression but add the sobering caveat that tumors may be able to quickly generate resistance by finding other ways to disrupt the p53 pathway.
Insights
Restoring tumor suppressor p53 function can trigger cancer regression in mice. However, tumors may develop resistance by bypassing the p53 pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Malignant tumors frequently disrupt the p53 signaling pathway for growth and survival.
- The p53 pathway is a critical regulator of cell cycle arrest, apoptosis, and DNA repair.
- Mutations in p53 are common in various human cancers.
Purpose of the Study:
- To investigate the therapeutic potential of restoring p53 function in cancer treatment.
- To evaluate whether p53 restoration alone is sufficient for tumor regression.
- To identify potential mechanisms of tumor resistance to p53-based therapies.
Main Methods:
- Studies involved restoring p53 function in mouse models of different tumor types.
- Researchers analyzed tumor regression following p53 pathway reactivation.
- Mechanisms of acquired resistance were investigated in subsequent experiments.
Main Results:
- Restoration of p53 function led to the regression of several types of tumors in mice.
- These findings suggest p53 reactivation as a potential cancer therapy.
- Tumors demonstrated the ability to rapidly develop resistance by circumventing the p53 pathway.
Conclusions:
- Restoring p53 activity shows promise as a potent anti-cancer strategy.
- Tumor resistance mechanisms can emerge quickly, posing a therapeutic challenge.
- Further research is needed to overcome resistance and develop effective p53-based cancer treatments.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
DNA Damage Can Stall the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...